Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Common Equity (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Common Equity for 8 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 1.51% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 1.51% increase, with the full-year FY2025 number at $2.0 billion, up 1.51% from a year prior.
  • Common Equity was $2.0 billion for Q4 2025 at Select Medical Holdings, roughly flat from $2.0 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $2.3 billion in Q3 2024 to a low of $1.3 billion in Q2 2022.
  • A 5-year average of $1.6 billion and a median of $1.5 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 49.01% in 2024, then dropped 11.4% in 2025.
  • Select Medical Holdings' Common Equity stood at $1.3 billion in 2021, then grew by 2.31% to $1.4 billion in 2022, then rose by 14.09% to $1.5 billion in 2023, then grew by 28.38% to $2.0 billion in 2024, then rose by 1.51% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for SEM's Common Equity are $2.0 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025).